The Mundipharma network’s K-Haler® exemplifies this: as winner of the A’ Design Platinum Awards for ‘Scientific Instruments, Medical Devices & Research Equipment Devices’ and ‘Ease of Use and Universal Design’, this inhaler incorporates novel enabling technology in a package that addresses several of the day-to-day challenges faced by patients who use an inhaler.
At the heart of the K-Haler is the patented k-valve®– a uniquely simple breath-triggered valve mechanism that releases the dose when the patient inhales. TTP took the original concept for the k-valve and demonstrated a successful manufacturing solution for the technology.
TTP then helped develop another key usability technology: the dose counter. As with the k-valve, TTP developed designs and production methods to overcome manufacturing challenges.
As a result, Mundipharma has launched a device that is not only smaller than other inhalers with similar functionality but also has a simpler mechanism, resulting from the use of fewer components.
30 years of innovation in the drug delivery field
